Home › Core › ISCC-IDs › 28CrZHkFjk6eY

View ISCC-ID

Core Data

28CrZHkFjk6eY
ISCC-ID - digital asset identifier
CCfV8wG7rUcPz-CTEjx2jc2Zykq-CDX2SCeh3zgi6-CRf24iKirDgdY
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

population pharmacokinetic and pharmacodynamic analysis of biib023 an antitnflike weak inducer of apoptosis antitweak monoclonal

Ledger Reference

coblo
Source Ledger/Blockchain
358087
N-th ISCC Decleration on source ledger
7841ffc3026f3951f4371cb9735560fdaa3272db40a55ef5df9cd14f14fa81f3
Hash of block that includes the ISCC-DECLARATION
b675ab4c4e5a7295c06de9d61feb591cc1aa774a9eeb72ac305c7919c4324935
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Gerald R. Galluppi", "@type": "Person"}, {"name": "Nicolas Wisniacki", "@type": "Person"}, {"name": "Chris Stebbins", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4917798?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1111/bcp.12914", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCfV8wG7rUcPz-CTEjx2jc2Zykq-CDX2SCeh3zgi6-CRf24iKirDgdY", "propertyID": "ISCC"}], "datePublished": "2016-04-08"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close